AI/ML Innovations Inc. (AIML.CN)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.06 CAD | -48.17% |
| 2022 | -0.04 CAD | 61.8% |
| 2021 | -0.10 CAD | 37.5% |
| 2020 | -0.16 CAD | -490.41% |
| 2019 | -0.03 CAD | -31.55% |
| 2018 | -0.02 CAD | -34.64% |
| 2017 | -0.02 CAD | -240.37% |
| 2016 | 0.01 CAD | 119.09% |
| 2015 | -0.06 CAD | 27.45% |
| 2014 | -0.08 CAD | -40.54% |
| 2013 | -0.06 CAD | 32.61% |
| 2012 | -0.08 CAD | 83.38% |
| 2011 | -0.50 CAD | -42.86% |
| 2010 | -0.35 CAD | -574.37% |
| 2009 | -0.05 CAD | 88.2% |
| 2008 | -0.44 CAD | 18.52% |
| 2007 | -0.54 CAD | -63.64% |
| 2006 | -0.33 CAD | 56.0% |
| 2005 | -0.75 CAD | -50.0% |
| 2004 | -0.50 CAD | 60.0% |
| 2003 | -1.25 CAD | -66.67% |
| 2002 | -0.75 CAD | 92.31% |
| 2001 | -9.75 CAD | -290.0% |
| 2000 | -2.50 CAD | 50.0% |
| 1999 | -5.00 CAD | 33.33% |
| 1998 | -7.50 CAD | 62.5% |
| 1997 | -20.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.00 CAD | 94.05% |
| 2023 Q2 | -0.01 CAD | -16.67% |
| 2023 Q1 | -0.01 CAD | -17.86% |
| 2023 Q4 | -0.03 CAD | -240.54% |
| 2023 Q3 | -0.01 CAD | 3.9% |
| 2022 Q4 | -0.01 CAD | 37.08% |
| 2022 Q1 | -0.02 CAD | 14.36% |
| 2022 Q2 | -0.01 CAD | 40.37% |
| 2022 Q3 | -0.01 CAD | 7.29% |
| 2022 FY | - CAD | 61.8% |
| 2021 Q1 | -0.03 CAD | -137.01% |
| 2021 Q3 | -0.02 CAD | 58.38% |
| 2021 Q4 | -0.02 CAD | -22.08% |
| 2021 FY | - CAD | 37.5% |
| 2021 Q2 | -0.04 CAD | -14.91% |
| 2020 Q2 | -0.00 CAD | -80.77% |
| 2020 FY | - CAD | -490.41% |
| 2020 Q4 | 0.09 CAD | 127.19% |
| 2020 Q3 | -0.32 CAD | -6708.51% |
| 2020 Q1 | -0.00 CAD | 71.74% |
| 2019 Q4 | -0.01 CAD | -113.95% |
| 2019 Q1 | -0.00 CAD | 18.33% |
| 2019 FY | - CAD | -31.55% |
| 2019 Q2 | -0.00 CAD | 57.14% |
| 2019 Q3 | -0.00 CAD | -104.76% |
| 2018 Q1 | -0.00 CAD | -325.0% |
| 2018 FY | - CAD | -34.64% |
| 2018 Q4 | -0.01 CAD | -3.45% |
| 2018 Q3 | -0.01 CAD | -13.73% |
| 2018 Q2 | -0.01 CAD | -50.0% |
| 2017 Q3 | -0.00 CAD | 26.67% |
| 2017 FY | - CAD | -240.37% |
| 2017 Q4 | -0.00 CAD | 81.82% |
| 2017 Q1 | -0.00 CAD | -146.99% |
| 2017 Q2 | -0.01 CAD | -53.85% |
| 2016 FY | - CAD | 119.09% |
| 2016 Q1 | 0.01 CAD | 128.91% |
| 2016 Q2 | -0.00 CAD | -108.2% |
| 2016 Q3 | -0.01 CAD | -760.0% |
| 2016 Q4 | 0.01 CAD | 196.51% |
| 2015 FY | - CAD | 27.45% |
| 2015 Q1 | -0.00 CAD | 88.08% |
| 2015 Q2 | -0.01 CAD | -36.96% |
| 2015 Q3 | -0.00 CAD | 36.51% |
| 2015 Q4 | -0.04 CAD | -955.0% |
| 2014 Q1 | -0.01 CAD | 35.57% |
| 2014 Q3 | -0.01 CAD | 37.65% |
| 2014 Q2 | -0.02 CAD | -36.0% |
| 2014 Q4 | -0.04 CAD | -264.15% |
| 2014 FY | - CAD | -40.54% |
| 2013 FY | - CAD | 32.61% |
| 2013 Q4 | -0.02 CAD | -94.0% |
| 2013 Q3 | -0.01 CAD | 35.48% |
| 2013 Q2 | -0.02 CAD | -40.91% |
| 2013 Q1 | -0.01 CAD | 40.54% |
| 2012 FY | - CAD | 83.38% |
| 2012 Q1 | -0.03 CAD | 45.28% |
| 2012 Q2 | -0.02 CAD | 27.45% |
| 2012 Q3 | -0.02 CAD | -11.35% |
| 2012 Q4 | -0.02 CAD | 10.19% |
| 2011 FY | - CAD | -42.86% |
| 2011 Q4 | -0.05 CAD | 66.71% |
| 2011 Q3 | -0.14 CAD | 46.15% |
| 2011 Q1 | -0.13 CAD | 53.57% |
| 2011 Q2 | -0.26 CAD | -100.0% |
| 2010 FY | - CAD | -574.37% |
| 2010 Q2 | -0.03 CAD | -150.0% |
| 2010 Q1 | -0.01 CAD | 37.97% |
| 2010 Q4 | -0.28 CAD | -862.2% |
| 2010 Q3 | -0.03 CAD | -0.34% |
| 2009 Q3 | -0.03 CAD | 47.6% |
| 2009 Q2 | -0.05 CAD | -30.16% |
| 2009 Q1 | -0.04 CAD | 84.67% |
| 2009 FY | - CAD | 88.2% |
| 2009 Q4 | -0.02 CAD | 25.5% |
| 2008 Q3 | -0.06 CAD | -57.71% |
| 2008 Q1 | -0.06 CAD | 74.92% |
| 2008 FY | - CAD | 18.52% |
| 2008 Q4 | -0.24 CAD | -304.72% |
| 2008 Q2 | -0.04 CAD | 40.03% |
| 2007 Q4 | -0.25 CAD | -365.55% |
| 2007 Q3 | -0.05 CAD | 66.44% |
| 2007 Q2 | -0.16 CAD | -146.15% |
| 2007 Q1 | -0.06 CAD | 45.83% |
| 2007 FY | - CAD | -63.64% |
| 2006 FY | - CAD | 56.0% |
| 2006 Q1 | -0.05 CAD | 77.92% |
| 2006 Q4 | -0.12 CAD | -35.14% |
| 2006 Q3 | -0.09 CAD | -127.11% |
| 2006 Q2 | -0.04 CAD | 26.23% |
| 2005 Q1 | -0.07 CAD | 76.46% |
| 2005 Q2 | -0.12 CAD | -82.09% |
| 2005 Q4 | -0.24 CAD | 4.0% |
| 2005 FY | - CAD | -50.0% |
| 2005 Q3 | -0.25 CAD | -108.33% |
| 2004 Q3 | -0.06 CAD | 26.43% |
| 2004 Q4 | -0.28 CAD | -335.46% |
| 2004 FY | - CAD | 60.0% |
| 2004 Q2 | -0.09 CAD | -10.21% |
| 2004 Q1 | -0.08 CAD | 86.09% |
| 2003 FY | - CAD | -66.67% |
| 2003 Q4 | -0.57 CAD | -185.0% |
| 2003 Q1 | -0.08 CAD | 46.13% |
| 2003 Q3 | -0.20 CAD | -25.0% |
| 2003 Q2 | -0.16 CAD | -98.02% |
| 2002 Q4 | -0.15 CAD | 0.0% |
| 2002 FY | - CAD | 92.31% |
| 2002 Q3 | -0.15 CAD | -500.0% |
| 2002 Q2 | -0.02 CAD | 83.33% |
| 2002 Q1 | -0.15 CAD | 98.49% |
| 2001 Q2 | -0.25 CAD | -286.4% |
| 2001 Q3 | -0.25 CAD | 0.0% |
| 2001 Q4 | -9.91 CAD | -3864.0% |
| 2001 FY | - CAD | -290.0% |
| 2001 Q1 | -0.06 CAD | 92.2% |
| 2000 Q1 | -0.10 CAD | 90.53% |
| 2000 Q4 | -0.83 CAD | -336.84% |
| 2000 Q2 | -0.17 CAD | -77.82% |
| 2000 Q3 | -0.19 CAD | -11.76% |
| 2000 FY | - CAD | 50.0% |
| 1999 FY | - CAD | 33.33% |
| 1999 Q4 | -1.01 CAD | 32.21% |
| 1999 Q2 | -2.50 CAD | 0.0% |
| 1999 Q1 | -2.50 CAD | 60.13% |
| 1999 Q3 | -1.49 CAD | 40.4% |
| 1998 FY | - CAD | 62.5% |
| 1998 Q1 | -2.50 CAD | 71.56% |
| 1998 Q3 | -0.92 CAD | 63.2% |
| 1998 Q2 | -2.50 CAD | 0.0% |
| 1998 Q4 | -6.27 CAD | -581.52% |
| 1997 Q4 | -8.79 CAD | -75.8% |
| 1997 Q1 | -2.50 CAD | 0.0% |
| 1997 Q3 | -5.00 CAD | -100.0% |
| 1997 FY | - CAD | 0.0% |
| 1997 Q2 | -2.50 CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Diagnamed Holdings Corp. | -0.02 CAD | -247.239% |
| Pangenomic Health Inc. | -0.30 CAD | 81.133% |
| nDatalyze Corp. | -0.00 CAD | -1315.0% |
| Treatment.Com International Inc. | -0.26 CAD | 78.231% |
| Unidoc Health Corp. | -0.04 CAD | -26.058% |